SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,533,087 | -64.8% | 32,605 | -68.6% | 0.01% | -66.7% |
| Q1 2023 | $4,352,553 | +117759.5% | 103,731 | +7.1% | 0.02% | +15.4% |
| Q4 2022 | $3,693 | -99.9% | 96,834 | 0.0% | 0.01% | -13.3% |
| Q3 2022 | $3,792,000 | -32.7% | 96,834 | -44.5% | 0.02% | -28.6% |
| Q2 2022 | $5,635,000 | +297.1% | 174,451 | +444.9% | 0.02% | +320.0% |
| Q3 2021 | $1,419,000 | +5.3% | 32,017 | +35.0% | 0.01% | 0.0% |
| Q2 2021 | $1,347,000 | +12.7% | 23,717 | +48.6% | 0.01% | 0.0% |
| Q1 2021 | $1,195,000 | – | 15,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
| Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
| Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
| BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
| TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
| Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
| RA Capital Management | 350,933 | $49,569,000 | 2.65% |
| Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
| OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |